UniProt ID | CLP1_HUMAN | |
---|---|---|
UniProt AC | Q92989 | |
Protein Name | Polyribonucleotide 5'-hydroxyl-kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035} | |
Gene Name | CLP1 {ECO:0000255|HAMAP-Rule:MF_03035} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 425 | |
Subcellular Localization | Nucleus . | |
Protein Description | Polynucleotide kinase that can phosphorylate the 5'-hydroxyl groups of double-stranded RNA (dsRNA), single-stranded RNA (ssRNA), double-stranded DNA (dsDNA) and double-stranded DNA:RNA hybrids. dsRNA is phosphorylated more efficiently than dsDNA, and the RNA component of a DNA:RNA hybrid is phosphorylated more efficiently than the DNA component. Plays a key role in both tRNA splicing and mRNA 3'-end formation. Component of the tRNA splicing endonuclease complex: phosphorylates the 5'-terminus of the tRNA 3'-exon during tRNA splicing; this phosphorylation event is a prerequisite for the subsequent ligation of the two exon halves and the production of a mature tRNA. [PubMed: 24766809] | |
Protein Sequence | MGEEANDDKKPTTKFELERETELRFEVEASQSVQLELLTGMAEIFGTELTRNKKFTFDAGAKVAVFTWHGCSVQLSGRTEVAYVSKDTPMLLYLNTHTALEQMRRQAEKEEERGPRVMVVGPTDVGKSTVCRLLLNYAVRLGRRPTYVELDVGQGSVSIPGTMGALYIERPADVEEGFSIQAPLVYHFGSTTPGTNIKLYNKITSRLADVFNQRCEVNRRASVSGCVINTCGWVKGSGYQALVHAASAFEVDVVVVLDQERLYNELKRDLPHFVRTVLLPKSGGVVERSKDFRRECRDERIREYFYGFRGCFYPHAFNVKFSDVKIYKVGAPTIPDSCLPLGMSQEDNQLKLVPVTPGRDMVHHLLSVSTAEGTEENLSETSVAGFIVVTSVDLEHQVFTVLSPAPRPLPKNFLLIMDIRFMDLK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Ubiquitination | GEEANDDKKPTTKFE CCCCCCCCCCCCCEE | 64.61 | 24816145 | |
12 | Phosphorylation | ANDDKKPTTKFELER CCCCCCCCCCEEEEE | 52.04 | 29759185 | |
13 | Phosphorylation | NDDKKPTTKFELERE CCCCCCCCCEEEEEE | 42.11 | 29759185 | |
30 | Phosphorylation | LRFEVEASQSVQLEL EEEEEEECHHHHHHH | 14.96 | - | |
32 | Phosphorylation | FEVEASQSVQLELLT EEEEECHHHHHHHHH | 14.88 | - | |
54 | Ubiquitination | TELTRNKKFTFDAGA CCCCCCCCEEECCCC | 53.86 | 29967540 | |
79 | Phosphorylation | SVQLSGRTEVAYVSK EEEECCCEEEEEEEC | 38.03 | 21406692 | |
83 | Phosphorylation | SGRTEVAYVSKDTPM CCCEEEEEEECCCCE | 15.49 | 21406692 | |
85 | Phosphorylation | RTEVAYVSKDTPMLL CEEEEEEECCCCEEE | 16.49 | 21406692 | |
88 | Phosphorylation | VAYVSKDTPMLLYLN EEEEECCCCEEEEEE | 17.84 | 24275569 | |
93 | Phosphorylation | KDTPMLLYLNTHTAL CCCCEEEEEEHHHHH | 8.24 | 24275569 | |
118 | Sulfoxidation | EERGPRVMVVGPTDV HHHCCCEEEECCCCC | 1.82 | 21406390 | |
127 | Ubiquitination | VGPTDVGKSTVCRLL ECCCCCCHHHHHHHH | 42.68 | 21963094 | |
202 | Ubiquitination | TNIKLYNKITSRLAD CCHHHHHHHHHHHHH | 33.53 | 29967540 | |
203 | Ubiquitination | NIKLYNKITSRLADV CHHHHHHHHHHHHHH | 3.63 | 27667366 | |
217 | Ubiquitination | VFNQRCEVNRRASVS HHHHCCCCCCCCCCC | 8.48 | 33845483 | |
222 | Phosphorylation | CEVNRRASVSGCVIN CCCCCCCCCCCEEEE | 18.27 | 27251275 | |
224 | Phosphorylation | VNRRASVSGCVINTC CCCCCCCCCEEEECC | 24.79 | 27251275 | |
256 | Ubiquitination | FEVDVVVVLDQERLY CCCEEEEEECHHHHH | 3.09 | 33845483 | |
261 | Ubiquitination | VVVLDQERLYNELKR EEEECHHHHHHHHHH | 36.52 | 33845483 | |
263 | Phosphorylation | VLDQERLYNELKRDL EECHHHHHHHHHHHC | 16.89 | 28152594 | |
264 | Ubiquitination | LDQERLYNELKRDLP ECHHHHHHHHHHHCC | 53.36 | 22817900 | |
267 | Acetylation | ERLYNELKRDLPHFV HHHHHHHHHHCCHHH | 37.37 | 25953088 | |
267 | Ubiquitination | ERLYNELKRDLPHFV HHHHHHHHHHCCHHH | 37.37 | 27667366 | |
281 | Ubiquitination | VRTVLLPKSGGVVER HEEEEECCCCCCEEC | 62.80 | 21906983 | |
282 | Phosphorylation | RTVLLPKSGGVVERS EEEEECCCCCCEECC | 38.55 | 30576142 | |
287 | Ubiquitination | PKSGGVVERSKDFRR CCCCCCEECCHHHHH | 49.16 | 21963094 | |
289 | Phosphorylation | SGGVVERSKDFRREC CCCCEECCHHHHHHH | 24.07 | 30576142 | |
313 | Phosphorylation | YGFRGCFYPHAFNVK HCCCCCCCCEEEEEE | 9.74 | - | |
320 | Acetylation | YPHAFNVKFSDVKIY CCEEEEEECCCCEEE | 40.01 | 26051181 | |
320 | Ubiquitination | YPHAFNVKFSDVKIY CCEEEEEECCCCEEE | 40.01 | 33845483 | |
325 | Ubiquitination | NVKFSDVKIYKVGAP EEECCCCEEEEECCC | 45.36 | 22817900 | |
328 | Ubiquitination | FSDVKIYKVGAPTIP CCCCEEEEECCCCCC | 37.35 | 22817900 | |
344 | Phosphorylation | SCLPLGMSQEDNQLK CCCCCCCCCCCCCEE | 28.72 | 25159151 | |
351 | Ubiquitination | SQEDNQLKLVPVTPG CCCCCCEEEEECCCC | 37.36 | 21963094 | |
356 | Phosphorylation | QLKLVPVTPGRDMVH CEEEEECCCCHHHHH | 17.60 | 23312004 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SEN2_HUMAN | TSEN2 | physical | 15109492 | |
SEN54_HUMAN | TSEN54 | physical | 15109492 | |
SEN34_HUMAN | TSEN34 | physical | 15109492 | |
CPSF5_HUMAN | NUDT21 | physical | 11060040 | |
CPSF2_HUMAN | CPSF2 | physical | 11060040 | |
CPSF6_HUMAN | CPSF6 | physical | 11060040 | |
CPSF7_HUMAN | CPSF7 | physical | 11060040 | |
CREB3_HUMAN | CREB3 | physical | 11384994 | |
A4_HUMAN | APP | physical | 21832049 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615803 | Pontocerebellar hypoplasia 10 (PCH10) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...